BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7700640)

  • 1. Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein.
    Baldari CT; Pelicci G; Di Somma MM; Milia E; Giuli S; Pelicci PG; Telford JL
    Oncogene; 1995 Mar; 10(6):1141-7. PubMed ID: 7700640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
    Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
    EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLP-76 binding to p56lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex.
    Sanzenbacher R; Kabelitz D; Janssen O
    J Immunol; 1999 Sep; 163(6):3143-52. PubMed ID: 10477581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
    Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
    Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A sensitivity of the HIV-1 long terminal repeat identifies distinct p56lck-dependent pathways activated by CD4 triggering.
    Di Somma MM; Majolini MB; Burastero SE; Telford JL; Baldari CT
    Eur J Immunol; 1996 Sep; 26(9):2181-8. PubMed ID: 8814265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sam68 association with p120GAP in CD4+ T cells is dependent on CD4 molecule expression.
    Jabado N; Jauliac S; Pallier A; Bernard F; Fischer A; Hivroz C
    J Immunol; 1998 Sep; 161(6):2798-803. PubMed ID: 9743338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation.
    Yokouchi M; Suzuki R; Masuhara M; Komiya S; Inoue A; Yoshimura A
    Oncogene; 1997 Jul; 15(1):7-15. PubMed ID: 9233773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding affinities of the SH2 domains of ZAP-70, p56lck and Shc to the zeta chain ITAMs of the T-cell receptor determined by surface plasmon resonance.
    Labadia ME; Ingraham RH; Schembri-King J; Morelock MM; Jakes S
    J Leukoc Biol; 1996 May; 59(5):740-6. PubMed ID: 8656061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P56lck A lymphocyte specific protein tyrosine kinase: activation, regulation and signal transduction.
    Fischer S; Marie-Cardine A; Ramos-Morales F; Bougeret C; Soula M; Maridonneau-Parini I; Benarous R
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):605-9. PubMed ID: 7981618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between the tyrosine kinases p56lck, p59fyn and p50csk in CD4 signaling in T cells.
    Baldari CT; Di Somma MM; Milia E; Bergman M; Telford JL
    Eur J Immunol; 1995 Apr; 25(4):919-25. PubMed ID: 7737294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct signaling properties identify functionally different CD4 epitopes.
    Baldari CT; Milia E; Di Somma MM; Baldoni F; Valitutti S; Telford JL
    Eur J Immunol; 1995 Jul; 25(7):1843-50. PubMed ID: 7542591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation.
    Veillette A; Fournel M
    Oncogene; 1990 Oct; 5(10):1455-62. PubMed ID: 2250907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine 474 of ZAP-70 is required for association with the Shc adaptor and for T-cell antigen receptor-dependent gene activation.
    Pacini S; Ulivieri C; Di Somma MM; Isacchi A; Lanfrancone L; Pelicci PG; Telford JL; Baldari CT
    J Biol Chem; 1998 Aug; 273(32):20487-93. PubMed ID: 9685404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytoplasmic domain of CD4 is required for stable association with the lymphocyte-specific tyrosine protein kinase p56lck.
    Veillette A; Sleckman BP; Ratnofsky S; Bolen JB; Burakoff SJ
    Eur J Immunol; 1990 Jun; 20(6):1397-400. PubMed ID: 2369920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside-induced CD4 endocytosis occurs independent of serine phosphorylation and is accompanied by dissociation of P56lck.
    Repke H; Barber E; Ulbricht S; Buchner K; Hucho F; Kopp R; Scholz H; Rudd CE; Haseltine WA
    J Immunol; 1992 Oct; 149(8):2585-91. PubMed ID: 1401895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between the amino-terminal domain of p56lck and cytoplasmic domains of CD4 and CD8 alpha in yeast.
    Campbell KS; Buder A; Deuschle U
    Eur J Immunol; 1995 Aug; 25(8):2408-12. PubMed ID: 7664803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.